![Maria Patrizia Caldirola](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maria Patrizia Caldirola
Vorstandsvorsitzender bei ClanoTech AB
Ursprung des Netzwerks ersten Grades von Maria Patrizia Caldirola
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Statistik
International
Schweden | 2 |
Dänemark | 2 |
Sektoral
Consumer Services | 3 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Founder | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Yihai Cao | 3 |
- Börse
- Insiders
- Maria Patrizia Caldirola
- Unternehmensverbindungen